Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer

Condition:   Advanced Esophageal Cancer
Interventions:   Drug: SHR-1210;   Drug: Placebo;   Drug: paclitaxel;   Drug: cisplatin
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting

https://ift.tt/2OsJI3O